Update of CARTITUDE-1: A phase Ib/II study of JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy, in relapsed/refractory multiple myeloma - Berdeja, J G; Madduri, D; Usmani, S Z
ASCO 2020; abstract 8505